• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于磺胺的杂环席夫碱衍生物作为潜在的碳酸酐酶抑制剂:合成、细胞毒性和酶抑制动力学。

Sulfonamide-Based Azaheterocyclic Schiff Base Derivatives as Potential Carbonic Anhydrase Inhibitors: Synthesis, Cytotoxicity, and Enzyme Inhibitory Kinetics.

机构信息

Department of Chemistry, Allama Iqbal Open University, Islamabad 44000, Pakistan.

Department of Chemistry, University of Gujrat, Gujrat-50700, Pakistan.

出版信息

Biomed Res Int. 2020 Feb 20;2020:8104107. doi: 10.1155/2020/8104107. eCollection 2020.

DOI:10.1155/2020/8104107
PMID:32149140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7054763/
Abstract

A series of sulfonamide-bearing azaheterocyclic Schiff base derivatives were synthesized as carbonic anhydrase inhibitors. The substituted benzene sulfonyl chlorides were reacted with NH to get aromatic sulfonyl hydrazides . The intermediate hydrazides were treated with substituted aldehydes to afford azaheterocyclic sulfonamide Schiff bases . The spectral data of synthesized compounds confirmed the formation of the final products. The inhibitory effects of on carbonic anhydrase activity were determined, and it was found that derivative exhibited the most potent activity with IC0.84 ± 0.12 M among all other derivatives and is also more active than standard acetazolamide (IC0.91 ± 0.12). The enzyme inhibitory kinetics results determined by Lineweaver-Burk plots revealed that compound inhibits the enzyme by noncompetitive mode of inhibition with value 8.6 M. The molecular docking investigations of the synthesized analogues were evaluated which assured that synthesized compounds bind well inside the active binding site of the target enzyme. Cytotoxicity on human keratinocyte (HaCaT) and MCF-7 cell lines was performed, and it was found that most of the synthesized analogues were nontoxic on these cell lines and the toxic effects follow the dose-dependent manner. Based on our investigations, it was suggested that analogue may serve as core structure to project carbonic anhydrase inhibitors with greater potency.

摘要

一系列含磺酰胺的氮杂杂环席夫碱衍生物被合成作为碳酸酐酶抑制剂。取代苯磺酰氯与 NH 反应得到芳基磺酰肼。中间体肼与取代的醛反应得到氮杂杂环磺酰胺席夫碱。合成化合物的光谱数据证实了最终产物的形成。测定了[化合物]对碳酸酐酶活性的抑制作用,发现衍生物[化合物]在所有其他衍生物中表现出最强的活性,IC0.84±0.12 M,比标准的乙酰唑胺(IC0.91±0.12 M)更具活性。Lineweaver-Burk 图确定的酶抑制动力学结果表明,化合物[化合物]通过非竞争性抑制模式抑制酶,Ki 值为 8.6 M。对合成类似物的分子对接研究进行了评估,结果表明合成化合物很好地结合在靶酶的活性结合位点内。对人角质形成细胞(HaCaT)和 MCF-7 细胞系进行了细胞毒性试验,结果发现大多数合成类似物对这些细胞系没有毒性,并且毒性作用呈剂量依赖性。基于我们的研究,建议类似物[化合物]可以作为设计具有更高效力的碳酸酐酶抑制剂的核心结构。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/7054763/00be86460661/BMRI2020-8104107.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/7054763/719a86b83d04/BMRI2020-8104107.sch.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/7054763/5f5ada8a92ef/BMRI2020-8104107.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/7054763/74cfa4726140/BMRI2020-8104107.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/7054763/01551ee44053/BMRI2020-8104107.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/7054763/310a392a3c98/BMRI2020-8104107.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/7054763/d8016acc904f/BMRI2020-8104107.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/7054763/eb6558fefe3c/BMRI2020-8104107.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/7054763/00be86460661/BMRI2020-8104107.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/7054763/719a86b83d04/BMRI2020-8104107.sch.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/7054763/5f5ada8a92ef/BMRI2020-8104107.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/7054763/74cfa4726140/BMRI2020-8104107.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/7054763/01551ee44053/BMRI2020-8104107.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/7054763/310a392a3c98/BMRI2020-8104107.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/7054763/d8016acc904f/BMRI2020-8104107.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/7054763/eb6558fefe3c/BMRI2020-8104107.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/7054763/00be86460661/BMRI2020-8104107.007.jpg

相似文献

1
Sulfonamide-Based Azaheterocyclic Schiff Base Derivatives as Potential Carbonic Anhydrase Inhibitors: Synthesis, Cytotoxicity, and Enzyme Inhibitory Kinetics.基于磺胺的杂环席夫碱衍生物作为潜在的碳酸酐酶抑制剂:合成、细胞毒性和酶抑制动力学。
Biomed Res Int. 2020 Feb 20;2020:8104107. doi: 10.1155/2020/8104107. eCollection 2020.
2
Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.新型芳香族和杂环双磺酰胺席夫碱作为碳酸酐酶I、II、VII和IX抑制剂的合成及生物学评价
Bioorg Med Chem. 2017 Jun 15;25(12):3093-3097. doi: 10.1016/j.bmc.2017.03.063. Epub 2017 Mar 31.
3
Carbonic anhydrase inhibitors: synthesis of Schiff bases of hydroxybenzaldehydes with aromatic sulfonamides and their reactions with arylsulfonyl isocyanates.碳酸酐酶抑制剂:羟基苯甲醛与芳族磺酰胺席夫碱的合成及其与芳基磺酰基异氰酸酯的反应。
J Enzyme Inhib. 2000;15(6):533-46. doi: 10.3109/14756360009040708.
4
Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors.双尾法在新型噻二嗪-苯磺酰胺杂合体的设计与合成中的应用,作为选择性碳酸酐酶抑制剂。
Eur J Med Chem. 2022 Jan 15;228:114004. doi: 10.1016/j.ejmech.2021.114004. Epub 2021 Nov 20.
5
Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.新型席夫碱对碳酸酐酶同工型I、II、IX和XII的抑制作用:肿瘤相关同工型相对于胞质同工型的选择性抑制剂的鉴定。
Bioorg Med Chem. 2014 Nov 1;22(21):5883-90. doi: 10.1016/j.bmc.2014.09.021. Epub 2014 Sep 21.
6
Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.香豆素-磺胺衍生物的合成及其细胞毒性、碳酸酐酶抑制活性和分子对接研究。
Eur J Med Chem. 2019 Dec 1;183:111702. doi: 10.1016/j.ejmech.2019.111702. Epub 2019 Sep 14.
7
Carbonic anhydrase inhibitors. Inhibition of human cytosolic isoforms I and II with (reduced) Schiff's bases incorporating sulfonamide, carboxylate and carboxymethyl moieties.碳酸酐酶抑制剂。含磺酰胺、羧酸盐和羧甲基部分的(还原)席夫碱对人胞质同工酶I和II的抑制作用。
Bioorg Med Chem. 2014 May 15;22(10):2867-74. doi: 10.1016/j.bmc.2014.03.041. Epub 2014 Apr 4.
8
Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII.具有对碳酸酐酶同工酶I、II、IX和XII有效抑制活性的新型吖啶双磺酰胺的合成。
Bioorg Med Chem. 2015 Oct 15;23(20):6573-80. doi: 10.1016/j.bmc.2015.09.022. Epub 2015 Sep 15.
9
New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.新型含氨茴酸的 N-苯磺酰胺邻苯二甲酰亚胺作为碳酸酐酶 I、II、IX 和 XII 的有效抑制剂:合成、体外测试和计算评估。
Eur J Med Chem. 2019 Nov 1;181:111573. doi: 10.1016/j.ejmech.2019.111573. Epub 2019 Aug 1.
10
Synthesis of 4-sulfamoylphenyl-benzylamine derivatives with inhibitory activity against human carbonic anhydrase isoforms I, II, IX and XII.具有抑制人碳酸酐酶同工酶I、II、IX和XII活性的4-氨磺酰基苯基-苄胺衍生物的合成。
Bioorg Med Chem. 2016 Mar 1;24(5):982-8. doi: 10.1016/j.bmc.2016.01.020. Epub 2016 Jan 11.

引用本文的文献

1
Synthesis, Computational Studies, Antioxidant and Anti-Inflammatory Bio-Evaluation of 2,5-Disubstituted-1,3,4-Oxadiazole Derivatives.2,5-二取代-1,3,4-恶二唑衍生物的合成、计算研究、抗氧化及抗炎生物活性评价
Pharmaceuticals (Basel). 2023 Jul 24;16(7):1045. doi: 10.3390/ph16071045.

本文引用的文献

1
The exploration of novel Alzheimer's therapeutic agents from the pool of FDA approved medicines using drug repositioning, enzyme inhibition and kinetic mechanism approaches.从 FDA 批准的药物库中通过药物重定位、酶抑制和动力学机制方法探索新型阿尔茨海默病治疗药物。
Biomed Pharmacother. 2019 Jan;109:2513-2526. doi: 10.1016/j.biopha.2018.11.115. Epub 2018 Dec 3.
2
Synthesis, carbonic anhydrase inhibitory activity and antioxidant activity of some 1,3-oxazine derivatives.一些 1,3-恶嗪衍生物的合成、碳酸酐酶抑制活性和抗氧化活性。
Drug Dev Res. 2018 Nov;79(7):352-361. doi: 10.1002/ddr.21464. Epub 2018 Oct 10.
3
Advances in structure-based drug discovery of carbonic anhydrase inhibitors.
基于结构的碳酸酐酶抑制剂药物发现进展
Expert Opin Drug Discov. 2017 Jan;12(1):61-88. doi: 10.1080/17460441.2017.1253677. Epub 2016 Nov 9.
4
Coumarin or benzoxazinone based novel carbonic anhydrase inhibitors: synthesis, molecular docking and anticonvulsant studies.基于香豆素或苯并恶嗪酮的新型碳酸酐酶抑制剂:合成、分子对接及抗惊厥研究
J Enzyme Inhib Med Chem. 2016 Oct;31(5):760-72. doi: 10.3109/14756366.2015.1063624. Epub 2015 Jul 24.
5
Poly(amidoamine) Dendrimers with Carbonic Anhydrase Inhibitory Activity and Antiglaucoma Action.具有碳酸酐酶抑制活性及抗青光眼作用的聚(酰胺胺)树枝状大分子
J Med Chem. 2015 May 14;58(9):4039-45. doi: 10.1021/acs.jmedchem.5b00383. Epub 2015 Apr 15.
6
Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum--the η-carbonic anhydrases.在疟疾病原体恶性疟原虫中发现一个新的碳酸酐酶家族——η-碳酸酐酶。
Bioorg Med Chem Lett. 2014 Sep 15;24(18):4389-4396. doi: 10.1016/j.bmcl.2014.08.015. Epub 2014 Aug 12.
7
Structural insight into activity enhancement and inhibition of H64A carbonic anhydrase II by imidazoles.咪唑类化合物增强和抑制 H64A 碳酸酐酶 II 活性的结构研究。
IUCrJ. 2014 Feb 28;1(Pt 2):129-35. doi: 10.1107/S2052252514004096. eCollection 2014 Mar 1.
8
Computational investigation of the selectivity of salen and tetrahydrosalen compounds towards the tumor-associated hCA XII isozyme.对萨伦和四氢萨伦化合物对肿瘤相关的人碳酸酐酶XII同工酶选择性的计算研究。
J Enzyme Inhib Med Chem. 2015 Feb;30(1):114-8. doi: 10.3109/14756366.2014.892936. Epub 2014 Mar 25.
9
Cell survival and metastasis regulation by Akt signaling in colorectal cancer.Akt 信号对结直肠癌中细胞存活和转移的调节。
Cell Signal. 2013 Aug;25(8):1711-9. doi: 10.1016/j.cellsig.2013.03.025. Epub 2013 Apr 18.
10
In vitro inhibition effect and structure-activity relationships of some saccharin derivatives on erythrocyte carbonic anhydrase I and II.某些糖精衍生物对红细胞碳酸酐酶 I 和 II 的体外抑制作用及构效关系。
J Enzyme Inhib Med Chem. 2014 Feb;29(1):118-23. doi: 10.3109/14756366.2012.757222. Epub 2013 Jan 23.